These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 26663780)

  • 41. Impact of age, sex and CMV-infection on peripheral T cell phenotypes: results from the Berlin BASE-II Study.
    Di Benedetto S; Derhovanessian E; Steinhagen-Thiessen E; Goldeck D; Müller L; Pawelec G
    Biogerontology; 2015 Oct; 16(5):631-43. PubMed ID: 25732234
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Patients at high risk for CMV infection and disease show delayed CD8+ T-cell immune recovery after allogeneic stem cell transplantation.
    Ganepola S; Gentilini C; Hilbers U; Lange T; Rieger K; Hofmann J; Maier M; Liebert UG; Niederwieser D; Engelmann E; Heilbronn R; Thiel E; Uharek L
    Bone Marrow Transplant; 2007 Mar; 39(5):293-9. PubMed ID: 17262060
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CMV driven CD8(+) T-cell activation is associated with acute rejection in lung transplantation.
    Roux A; Mourin G; Fastenackels S; Almeida JR; Iglesias MC; Boyd A; Gostick E; Larsen M; Price DA; Sacre K; Douek DC; Autran B; Picard C; Miranda Sd; Sauce D; Stern M; Appay V
    Clin Immunol; 2013 Jul; 148(1):16-26. PubMed ID: 23644452
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytomegalovirus-specific CD4 and CD8 T cell responses in infants and children.
    Lidehäll AK; Engman ML; Sund F; Malm G; Lewensohn-Fuchs I; Ewald U; Tötterman TH; Karltorp E; Korsgren O; Eriksson BM
    Scand J Immunol; 2013 Feb; 77(2):135-43. PubMed ID: 23216075
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy.
    Keane NM; Price P; Lee S; Almeida CA; Stone SF; James I; French MA
    HIV Med; 2004 Nov; 5(6):407-14. PubMed ID: 15544692
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Simultaneous activation of viral antigen-specific memory CD4+ and CD8+ T-cells using mRNA-electroporated CD40-activated autologous B-cells.
    Van den Bosch GA; Van Gulck E; Ponsaerts P; Nijs G; Lenjou M; Apers L; Kint I; Heyndrickx L; Vanham G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
    J Immunother; 2006; 29(5):512-23. PubMed ID: 16971807
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical significance of CMV-specific T helper responses in lung transplant recipients.
    Zeevi A; Morel P; Spichty K; Dauber J; Yousem S; Williams P; Grgurich W; Pham S; Iacono A; Keenan R; Duquesnoy R; Griffith B
    Hum Immunol; 1998 Dec; 59(12):768-75. PubMed ID: 9831132
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of cytomegalovirus infection on immune cell phenotypes in patients with common variable immunodeficiency.
    Marashi SM; Raeiszadeh M; Enright V; Tahami F; Workman S; Chee R; Webster AD; Milne RS; Emery VC
    J Allergy Clin Immunol; 2012 May; 129(5):1349-1356.e3. PubMed ID: 22444511
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationship of reconstituted adaptive and innate cytomegalovirus (CMV)-specific immune responses with CMV viremia in hematopoietic stem cell transplant recipients.
    Barron MA; Gao D; Springer KL; Patterson JA; Brunvand MW; McSweeney PA; Zeng C; Barón AE; Weinberg A
    Clin Infect Dis; 2009 Dec; 49(12):1777-83. PubMed ID: 19911937
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Timing of CMV-specific effector memory T cells predicts viral replication and survival after allogeneic hematopoietic stem cell transplantation.
    Espigado I; de la Cruz-Vicente F; BenMarzouk-Hidalgo OJ; Gracia-Ahufinger I; Garcia-Lozano JR; Aguilar-Guisado M; Cisneros JM; Urbano-Ispizua A; Perez-Romero P
    Transpl Int; 2014 Dec; 27(12):1253-62. PubMed ID: 25070273
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cellular immune parameters associated with spontaneous control of CMV in children who underwent transplantation.
    Guérin V; Dalle JH; Pédron B; Ouachée-Chardin M; Yakouben K; Baruchel A; Sterkers G
    Bone Marrow Transplant; 2010 Mar; 45(3):442-9. PubMed ID: 19633694
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Poor predictive value of cytomegalovirus (CMV)-specific T cell assays for the development of CMV retinitis in patients with AIDS.
    Jacobson MA; Tan QX; Girling V; Poon C; Van Natta M; Jabs DA; Inokuma M; Maecker HT; Bredt B; Sinclair E;
    Clin Infect Dis; 2008 Feb; 46(3):458-66. PubMed ID: 18173357
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Perforin and IL-2 upregulation define qualitative differences among highly functional virus-specific human CD8 T cells.
    Makedonas G; Hutnick N; Haney D; Amick AC; Gardner J; Cosma G; Hersperger AR; Dolfi D; Wherry EJ; Ferrari G; Betts MR
    PLoS Pathog; 2010 Mar; 6(3):e1000798. PubMed ID: 20221423
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CMV-specific T-cell immunity, viral load, and clinical outcome in seropositive renal transplant recipients: a pilot study.
    Sund F; Lidehäll AK; Claesson K; Foss A; Tötterman TH; Korsgren O; Eriksson BM
    Clin Transplant; 2010; 24(3):401-9. PubMed ID: 19222507
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytotoxic polyfunctionality maturation of cytomegalovirus-pp65-specific CD4 + and CD8 + T-cell responses in older adults positively correlates with response size.
    Chiu YL; Lin CH; Sung BY; Chuang YF; Schneck JP; Kern F; Pawelec G; Wang GC
    Sci Rep; 2016 Jan; 6():19227. PubMed ID: 26778409
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Flow cytometric analysis of cytomegalovirus-specific cell-mediated immunity in the congenital infection.
    Hayashi N; Kimura H; Morishima T; Tanaka N; Tsurumi T; Kuzushima K
    J Med Virol; 2003 Oct; 71(2):251-8. PubMed ID: 12938200
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of key peptide-specific CD4+ T cell responses to human cytomegalovirus: implications for tracking antiviral populations.
    Harcourt GC; Scriba TJ; Semmo N; Bounds S; Taylor E; Klenerman P
    Clin Exp Immunol; 2006 Nov; 146(2):203-10. PubMed ID: 17034571
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ex vivo monitoring of human cytomegalovirus-specific CD8(+) T-Cell responses using the QuantiFERON-CMV assay in allogeneic hematopoietic stem cell transplant recipients attending an Irish hospital.
    Fleming T; Dunne J; Crowley B
    J Med Virol; 2010 Mar; 82(3):433-40. PubMed ID: 20087937
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pretransplant CD8 T-cell response to IE-1 discriminates seropositive kidney recipients at risk of developing CMV infection posttransplant.
    López-Oliva MO; Martinez V; Buitrago A; Jiménez C; Rivas B; Escuin F; Santana MJ; Selgas R; Bellón T
    Transplantation; 2014 Apr; 97(8):839-45. PubMed ID: 24345896
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytomegalovirus Infection Leads to Development of High Frequencies of Cytotoxic Virus-Specific CD4+ T Cells Targeted to Vascular Endothelium.
    Pachnio A; Ciaurriz M; Begum J; Lal N; Zuo J; Beggs A; Moss P
    PLoS Pathog; 2016 Sep; 12(9):e1005832. PubMed ID: 27606804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.